Bellicum Pharmaceuticals, Inc. (BLCM)
OTCMKTS: BLCM · Delayed Price · USD
0.226
+0.036 (18.95%)
Nov 27, 2023, 3:25 PM EST - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.5 | 6.2 | 0.5 | 7.14 | 1.12 | 0.19 | 0.39 | 0.28 | 1.78 | 1.94 | Upgrade
|
| Revenue Growth (YoY) | -75.81% | 1140.00% | -93.00% | 537.77% | 505.41% | -52.32% | 37.59% | -84.16% | -8.28% | 31.99% | Upgrade
|
| Gross Profit | 1.5 | 6.2 | 0.5 | 7.14 | 1.12 | 0.19 | 0.39 | 0.28 | 1.78 | 1.94 | Upgrade
|
| General & Administrative | 5.72 | 7.01 | 15.53 | 29.97 | 25.43 | 21.91 | 17.51 | 15.86 | 5.4 | 2.81 | Upgrade
|
| Research & Development | 22.76 | 23.58 | 39.05 | 64.54 | 71.15 | 65.66 | 51.26 | 33.56 | 11.01 | 7.05 | Upgrade
|
| Other Operating Expenses | 0 | 0.01 | 0.11 | -2.99 | 0.44 | 0.86 | 0.58 | 3.18 | 43,212 | 0 | Upgrade
|
| Operating Expenses | 28.48 | 30.59 | 54.58 | 94.51 | 96.59 | 87.57 | 68.77 | 49.42 | 16.41 | 9.86 | Upgrade
|
| Operating Income | -26.98 | -24.87 | -51.69 | -87.36 | -95.47 | -87.39 | -68.38 | -49.14 | -57.84 | -7.92 | Upgrade
|
| Interest Income | 0 | 0.03 | 0.39 | 1.35 | 1.64 | 1.06 | 0.91 | 0.64 | 0.03 | 0 | Upgrade
|
| Interest Expense | 0 | 0 | 2.66 | 4.28 | 4.2 | 3.67 | 1.76 | 0.01 | 1.76 | 0.05 | Upgrade
|
| Other Expense / Income | -2.01 | -15.13 | -46.24 | 22.18 | -1.62 | -1.9 | 1.47 | 0.03 | 23.32 | -0 | Upgrade
|
| Pretax Income | -24.97 | -9.71 | -7.72 | -112.48 | -98.04 | -91.78 | -69.24 | -48.55 | -83.97 | -7.97 | Upgrade
|
| Income Tax | 0 | -0.13 | 0.9 | 13.62 | 1.63 | 3.67 | -1.46 | 0.01 | 1.09 | 0 | Upgrade
|
| Net Income | -24.97 | -9.58 | -8.62 | -126.09 | -98.04 | -91.78 | -69.24 | -48.55 | -83.97 | -7.97 | Upgrade
|
| Shares Outstanding (Basic) | 31 | 12 | 6 | 5 | 4 | 3 | 3 | 3 | 3 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 31 | 12 | 6 | 5 | 4 | 3 | 3 | 3 | 3 | 1 | Upgrade
|
| Shares Change | 167.97% | 99.72% | 22.96% | 16.45% | 26.85% | 17.67% | 2.29% | 5.01% | 155.29% | - | Upgrade
|
| EPS (Basic) | -0.81 | -0.83 | -1.50 | -26.92 | -24.37 | -28.94 | -25.69 | -18.43 | -33.47 | -8.11 | Upgrade
|
| EPS (Diluted) | -0.81 | -0.83 | -1.50 | -26.92 | -24.37 | -28.94 | -25.69 | -18.43 | -33.47 | -8.11 | Upgrade
|
| Free Cash Flow | -25.8 | -23.11 | -57.28 | -78.09 | -76.4 | -85.12 | -57.66 | -41.15 | -58.11 | -7.98 | Upgrade
|
| Free Cash Flow Per Share | -0.84 | -2.01 | -9.94 | -16.67 | -18.99 | -26.84 | -21.39 | -15.62 | -23.16 | -8.12 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -1798.73% | -401.06% | -10338.40% | -1223.07% | -8523.75% | -47236.22% | -17623.71% | -17423.76% | -3249.33% | -408.21% | Upgrade
|
| Profit Margin | -1664.87% | -154.48% | -1723.80% | -1765.25% | -8753.21% | -49610.27% | -17845.62% | -17215.60% | -4717.13% | -410.62% | Upgrade
|
| Free Cash Flow Margin | -1720.27% | -372.79% | -11455.00% | -1093.25% | -6821.34% | -46009.73% | -14861.08% | -14591.13% | -3264.71% | -411.14% | Upgrade
|
| EBITDA | -28.93 | -24.35 | -53.58 | -68.17 | -95.47 | -82.77 | -68.38 | -47.3 | -14.63 | -7.33 | Upgrade
|
| EBITDA Margin | -1928.93% | -392.73% | -10716.80% | -954.39% | -8523.75% | -44739.46% | -17623.71% | -16771.28% | -821.69% | -377.75% | Upgrade
|
| Depreciation & Amortization | 0.01 | 0.14 | 1.87 | 8.51 | 6.7 | 3.56 | 2.31 | 1.2 | 0.67 | 0.59 | Upgrade
|
| EBIT | -28.95 | -24.49 | -55.46 | -76.68 | -102.16 | -86.33 | -70.69 | -48.49 | -15.29 | -7.92 | Upgrade
|
| EBIT Margin | -1929.67% | -394.95% | -11091.60% | -1073.47% | -9121.79% | -46665.95% | -18218.04% | -17196.45% | -859.14% | -408.01% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.